Our mission is to enable scientists and entrepreneurs to build the companies that solve the world’s toughest problems.

In partnership with the University of Oxford, OSI invests in fundamental technology companies, built on science. We match Oxford’s scientists with experienced entrepreneurs to turn idea to impact, discovery to company.

squares-animation-white
news-block-pic-1

Explore our portfolio

Read more
news-block-pic-2
news-block-pic-3
news-block-pic-4
news-block-pic-5
news-block-pic-6
news-block-pic-7

Latest news from the OSI network

Read more

Updates

We are delighted to announce the official launch of Base Genomics and that we have closed a seed funding round of $11 million USD to support development of our breakthrough technology towards a highly sensitive blood test for cancer.

https://lnkd.in/dTii8ye

Welcome to the portfolio @BaseGenomics and congrats to Oliver Waterhouse, former EiR at OSI! 🧬

Borne out of the Ludwig Institute for Cancer Research Branch at the @UniofOxford, TAPS technology sets a new gold standard in DNA methylation sequencing.

https://www.basegenomics.com/base-genomics-announces-company-launch-and-raises-11-million-usd